Program Overview

High quality statistical support is important in the preparation of grant applications or study protocols for clinical trials. Such support typically is not readily available to investigators who are new to clinical trials. To address this weakness, the NeuroDiscovery Center provides expert consultation and collaboration on all biostatistical aspects of biomedical and clinical research applicable to Alzheimer’s disease.

Since its inception, the biostatistics program has collaborated with over 117 investigators on 289 projects from across the Harvard medical community. These projects have focused on a spectrum of neurodegenerative diseases and have included clinical trials, observational studies, basic science experiments and animal studies. The research has covered genetics, imaging and clinical endpoints such as progression and survival, and we have collaborated on study design for research grants and clinical trial protocols, data analysis and development of new statistical methods.